Evidence map›Paper›PMID 24832453›Full record

ArticleCell host & microbe2014

Genomic analyses of pneumococci from children with sickle cell disease expose host-specific bacterial adaptations and deficits in current interventions.

Robert Carter, Joshua Wolf, Tim van Opijnen, Martha Muller, Caroline Obert, Corinna Burnham, Beth Mann, Yimei Li, Randall T Hayden, Tamara Pestina and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell host & microbe, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 66 citations in OpenAlex.

  1. Review
  2. Genomic Characterization ofMicroorganisms · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Biological puzzles solved by usingJournal of bacteriology · 2024
    Review
  8. PepO and CppA modulateVirulence · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Experimental EvolutionmSystems · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Robert Carter *Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105 USA.
Joshua Wolf *Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105 USA.
Tim van Opijnen *Tufts University School of Medicine, Department of Molecular Biology and Microbiology, 136 Harrison Avenue, Boston, MA 02111-1817 USA.
Martha MullerDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105 USA.
Caroline ObertDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105 USA.
Corinna BurnhamDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105 USA.
Beth MannDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105 USA.
Yimei LiDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN 38105 USA.
Randall T HaydenDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105 USA.
Tamara PestinaDepartment of Experimental Hematology, St. Jude Children's Research Hospital, Memphis, TN 38105 USA.
Derek PersonsDepartment of Experimental Hematology, St. Jude Children's Research Hospital, Memphis, TN 38105 USA.
Andrew CamilliTufts University School of Medicine, Department of Molecular Biology and Microbiology, 136 Harrison Avenue, Boston, MA 02111-1817 USA.
Patricia M Flynn *Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105 USA.
Elaine I Tuomanen *Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105 USA.
Jason W Rosch *Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105 USA.
St. Jude Children's Research Hospital · USTufts University · US

Funding

Y-Globin Gene Therapy Using In Vivo SelectionU54HL070590 · NHLBI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI TUOMANEN, ELAINE I · 2003 to 2011
$13.8M
PNEUMOCOCCAL CELL WALL IN MENINGITISR01AI027913 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI TUOMANEN, ELAINE I · 1989 to 2015
$5.2M
NHLBI NIH HHS U54 HL-070590NHLBI NIH HHS U54 HL070590NIAID NIH HHS R01 AI027913NIAID NIH HHS R01-AI27913
6 · The paper itself

Abstract

Sickle cell disease (SCD) patients are at high risk of contracting pneumococcal infection. To address this risk, they receive pneumococcal vaccines, and antibiotic prophylaxis and treatment. To assess the impact of SCD and these interventions on pneumococcal genetic architecture, we examined the genomes of more than 300 pneumococcal isolates from SCD patients over 20 years. Modern SCD strains retained invasive capacity but shifted away from the serotypes used in vaccines. These strains had specific genetic changes related to antibiotic resistance, capsule biosynthesis, metabolism, and metal transport. A murine SCD model coupled with Tn-seq mutagenesis identified 60 noncapsular pneumococcal genes under differential selective pressure in SCD, which correlated with aspects of SCD pathophysiology. Further, virulence determinants in the SCD context were distinct from the general population, and protective capacity of potential antigens was lost over time in SCD. This highlights the importance of understanding bacterial pathogenesis in the context of high-risk individuals.

Indexed as

Host-Pathogen InteractionsAdaptation, PhysiologicalAdolescentAnemia, Sickle CellBacterial ProteinsChildChild, PreschoolFemaleGenomicsHumansInfantMaleMolecular Sequence DataPhylogenyPneumococcal InfectionsPneumococcal VaccinesBacterial ProteinsPneumococcal Vaccines

Identifiers

PMID24832453
PMCPMC4066559
OpenAlexW2006132751

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.